Cystatin C and cathepsin B in human colon carcinoma: expression by cell lines and matrix degradation.
about
Cysteine proteinase inhibitor cystatin C in squamous cell carcinoma of the head and neck: relation to prognosisMolecular regulation of human cathepsin B: implication in pathologiesBiochemistry and clinical role of human cystatin C.Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages.Salivary (SD-type) cystatins: over one billion years in the making--but to what purpose?Cathepsin B and other proteases in human colorectal carcinoma.Expression of cystatin C and its effect on EC9706 cells in esophageal carcinoma.Aging stem cells, latexin, and longevity.Intracellular accumulation of the amyloidogenic L68Q variant of human cystatin C in NIH/3T3 cells.Clinical significance of CD146 and latexin during different stages of thyroid cancer.The role of vascular permeability factor and basic fibroblast growth factor in tumor angiogenesis.Characterization of a cysteine proteinase inhibitor induced during neuronal cell differentiation.Exocytosis of active cathepsin B enzyme activity at pH 7.0, inhibition and molecular mass.Cystatins in health and disease.An active zymogen: unravelling the mystery of tissue-type plasminogen activator.Detection of cathepsin B, cathepsin L, cystatin C, urokinase plasminogen activator and urokinase plasminogen activator receptor in the sera of lung cancer patients.Cytostatic Agents in the Management of Malignant Gliomas.Instability of the Amyloidogenic Cystatin C Variant of Hereditary Cerebral Hemorrhage with Amyloidosis, Icelandic Type
P2860
Q24646038-B318A8DF-7948-4C22-B36F-C9022333480AQ28190363-04D32D8B-132B-42FA-8439-7192D2059F3BQ34377103-2CE8043A-FA2A-4168-9DB5-934ACDF848CBQ34385281-26B2CC57-B961-4488-A2A0-85C09D22363EQ35033473-EA95589A-9173-40E8-AC06-0BDC30CAD373Q35833965-BA99E8A8-0405-455E-9E99-C604A81E3B35Q36261285-DC8A62FB-F3D6-4482-8AB4-0F79775968EAQ37122443-35718906-39E0-489A-80A3-BA7931F04C5DQ37641582-F735F9A1-FAA5-43FE-89DC-A302181185D9Q39146799-F0706B14-FCC1-4EE2-9188-BB8ECC9320A7Q40401867-AB6B00FB-84C3-41E6-8221-196D5EB6DFCEQ40725030-A958235C-AC6C-4A69-9C8C-DB5C55D28D27Q40935441-48702D03-1B98-44B7-B108-C8764A002FE4Q41161690-0DF05F21-15F3-4BA0-83BC-5EAE40448BF5Q41730397-5E2E46B8-CD56-4D6B-9CC7-EB5A5E10CB5CQ41913783-075FA363-CBF4-4F03-8959-8DEA3C0C378BQ54055855-B7BD8F58-3305-4B13-9076-EF43D13F06E9Q57839803-6F7A80BC-4E90-47D7-90EE-7B2E327E6AD5
P2860
Cystatin C and cathepsin B in human colon carcinoma: expression by cell lines and matrix degradation.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Cystatin C and cathepsin B in ...... lines and matrix degradation.
@en
type
label
Cystatin C and cathepsin B in ...... lines and matrix degradation.
@en
prefLabel
Cystatin C and cathepsin B in ...... lines and matrix degradation.
@en
P2093
P2860
P356
P1476
Cystatin C and cathepsin B in ...... lines and matrix degradation.
@en
P2093
M Abrahamson
O Corticchiato
P2860
P304
P356
10.1002/IJC.2910520425
P577
1992-10-01T00:00:00Z